* Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected
to show a
rise in quarterly revenue when it reports results on November
8.
* The Solana Beach California-based company is expected to
report
a 18.2% increase in revenue to $5.405 million from $4.57
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Clearpoint Neuro
Inc is
for a loss of 19 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $20.25, above its last closing price of $9.77.
This summary was machine generated November 4 at 23:20 GMT. All
figures in US dollars unless otherwise stated